Gayatri Reilly, MD
Retina Specialist · Chevy Chase, MDNPI 1174718456
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $516 and has fallen 53.7% since, to $239 in 2025. That places this record below the midpoint for retina specialist clinicians in MD, where the typical reported total is $3,416.
Across 48 payments — averaging $39.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$378
- Genentech USA, Inc.$200
- Regeneron Healthcare Solutions, Inc.$185
- Biotissue Holdings Inc.$148
- Bausch & Lomb Americas Inc.$123
- Shire North American Group Inc$123
- plus $751 from 9 others
Across 76 payments — averaging $12,568 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$942K
- Regeneron$14K
What the payments were for
- Food & beverage$1,907100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $378 |
| Genentech USA, Inc. | 10 | $200 |
| Regeneron Healthcare Solutions, Inc. | 5 | $185 |
| Biotissue Holdings Inc. | 1 | $148 |
| Bausch & Lomb Americas Inc. | 1 | $123 |
| Shire North American Group Inc | 1 | $123 |
| Mallinckrodt Hospital Products Inc. | 3 | $118 |
| Sun Pharmaceutical Industries Inc. | 1 | $116 |
| Astellas Pharma US Inc | 4 | $111 |
| Alcon | 1 | $102 |
| Apellis Pharmaceuticals, Inc. | 1 | $98 |
| Eyepoint US, Inc. | 2 | $91 |
| Novartis | 3 | $70 |
| Alimera Sciences, Inc. | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$148
- AmnioGraft$148
- IC-8 Apthera IOL$123
- enVista MX60 IOL$123
- XIIDRA$123
- CEQUA$116
- Clareon$102
How this compares
$1,907 in reported general payments places this provider in the 40th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 72 | $3,729 |
| Ketorolac Tromethamine | 59 | $1,134 |
| Ofloxacin | 50 | $764 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Chevy Chase
- Brian DoChevy Chase$116K
- Michael LaiChevy Chase$13K
- Richard GarfinkelChevy Chase$5K
- Daniel BerinsteinChevy Chase$1K
- Rohit LakhanpalOwings Mills$168K
- Adam GerstenblithHagerstown$107K
- Aziz KhanifarSilver Spring$83K
- Michael ElmanBaltimore$27K
- Reginald SandersGreenbelt$24K
- Sidney SchechetBaltimore$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.